Dividend Update: February 23

 General Overview

After the hooray of Januar and the start of the new year, in February the market felt a little less enthusiastic. More and more earnings were published, ranging from encouraging over mediocre to disappointing (I see you there, Intel!). On the whole, my portfolio was very much in line with the MSCI World and dropped by a minuscule -0.21%. I also always knew that February was going to be one of my weakest (if not my weakest) months with regards to dividends and this turns out to be true. In February, I collected 236,18€ in total. I hope this is going to be one of the fewer months (or better yet: the only one) below 300€. YoY, it is at least still an 27% increase, but March should prove to be a higher-yielding month.

• AT&T: 9,10
  
• Verizon: 9,68
  
• Apple: 5,44
  
• AGNC: 5,04
  
• ASML: 2,46
  
• AbbVie: 11,76
  
• SL Green Realty: 2,37
  
• Stag Industrial: 0,49
  
• National Retail Properties: 4,36
  
• Kinder Morgan: 6,62
  
• Main Street: 17,42
  
• Omega Healthcare: 37,28
  
• Realty Income: 27,46
  
• SPDR Global Dividend Aristocrats ETF: 24,28
• Siemens: 0,34
  
• British American Tobacco: 13,63
  
• Texas Instruments: 8,83
  
• Starbucks: 14,37
  
• LTC: 2,59
  
• EPR Properties: 3,06
  
• Sabra Health Care Reit: 9,61
• Calamos Strategic Total Return Fund: 3,38
• Blackrock Utilities, Infrastructure & Power Opportunities Trust: 3,33
  
• Blackrock Science and Technology Trust II: 4,80
  
• Cohen & Steers REIT & Preferred Income Fund: 2,26
  
• Cohen&Steers Quality Realty Income Fund: 2,33
  

Winners & Losers

Biggest climbers this month were BP (+12), Shell (+10), MainStreet (+10), all on excellent earnings. Biggest losers were the endless troublesome Medical Properties Trust (-18) on which there is still a rather spirited debate going on and Newtek Business Service (-15) after completing their announced transition from a high-yielding BDC to a regional bank.